FAGR Fagron SA

Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast acquisitions

Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast acquisitions

Regulated information - inside information

Nazareth (Belgium)/Rotterdam (The Netherlands), 6 October 2025 – 7:00 AM CET

Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast acquisitions

Fagron, the leading global player in pharmaceutical compounding, announces that the Brazilian competition authority, CADE, has granted clearance for the previously announced acquisitions of Purifarma and Injeplast in Brazil.

The clearances represent an important step forward in executing Fagron’s disciplined M&A strategy in Latin America. The transactions will broaden Fagron’s portfolio and capabilities in Brazil, supporting the Group’s ambition to build a scalable, high-quality platform aligned with its long-term growth objectives.

Purifarma operates a highly concentrated Essentials portfolio at very large volumes, presenting significant potential to improve profitability within 18 months post-closing through enhanced product portfolio and brands expansion, as well as increased operational leverage and procurement savings. In addition, the scale-up is expected to generate procurement benefits not only across Latin America but throughout our entire global footprint.

Injeplast will further strengthen Fagron’s vertical integration by producing high-quality packaging solutions and efficient manufacturing processes, supporting our Essentials strategy by broadening our product portfolio and customer base in Latin America as well as other regions.

Completion of the acquisitions remains subject to customary closing conditions and completion of certain local corporate and contractual formalities.

Rafael Padilla, CEO of Fagron, commented:

“CADE’s approvals allow us to progress towards closing Purifarma and Injeplast. These acquisitions strengthen our leadership position in Brazil and complement our strategy to combine targeted M&A with operational excellence while maintain financial discipline.”

Financial calendar 2025

9 October 2025                Trading update third quarter 2025

Results and trading updates are published at 7.00 AM CET.

Further information

Ignacio Artola

Global Investor Relations Leader

Tel.

About Fagron

Fagron is the leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics, and patients in more than 35 countries around the world.

The Belgian company Fagron NV is based on Venecoweg 20A in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed through the Dutch company Fagron BV. Fagron BV’s head office is located in Rotterdam.

Important information regarding forward-looking statements

Certain statements in this press release may be deemed to be forward-looking. Such forward-looking statements are based on current expectations and are influenced by various risks and uncertainties. Consequently, Fagron cannot provide any guarantee that such forward-looking statements will, in fact, materialize and cannot accept any obligation to update or revise any forward-looking statement as a result of new information, future events or for any other reason.

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

Attachment



EN
06/10/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Fagron SA

 PRESS RELEASE

Fagron’s share buy-back program: Weekly update

Fagron’s share buy-back program: Weekly update Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 31 October 2025 – 6PM CET Fagron’s share buy-back program: Weekly update In the period from 27 October 2025 through 31 October 2025, Fagron purchased 46,000 of its owns shares at an average price of €20.5831 per share corresponding to a total amount of €946,821.80. These purchases are part of the share buy-back program of up to 200,000 Fagron shares to fulfill Fagron’s obligations under its long-term incentive scheme, which was announced on 9 October 2025. The total numbe...

 PRESS RELEASE

Voortgang aandeleninkoopprogramma Fagron

Voortgang aandeleninkoopprogramma Fagron Gereglementeerde informatie Nazareth (België)/Rotterdam (Nederland), 31 oktober 2025 – 18u CET Voortgang aandeleninkoopprogramma Fagron In de periode van 27 oktober 2025 tot en met 31 oktober 2025 heeft Fagron 46.000 eigen aandelen ingekocht voor een gemiddelde prijs van € 20.5831 per aandeel wat overeenkomt met een totaalbedrag van € 946.821,80. Deze aankopen zijn gedaan als onderdeel van het aandeleninkoopprogramma van maximaal 200.000 Fagron aandelen ter afdekking van Fagron’s verplichtingen uit hoofde van haar langetermijn variabele belonings...

 PRESS RELEASE

Fagron’s share buy-back program: Weekly update

Fagron’s share buy-back program: Weekly update Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 24 October 2025 – 6PM CET Fagron’s share buy-back program: Weekly update In the period from 20 October 2025 through 24 October 2025, Fagron purchased 45,000 of its owns shares at an average price of €21.0115 per share corresponding to a total amount of €945,517.50. These purchases are part of the share buy-back program of up to 200,000 Fagron shares to fulfill Fagron’s obligations under its long-term incentive scheme, which was announced on 9 October 2025. The total numbe...

 PRESS RELEASE

Voortgang aandeleninkoopprogramma Fagron

Voortgang aandeleninkoopprogramma Fagron Gereglementeerde informatie Nazareth (België)/Rotterdam (Nederland), 24 oktober 2025 – 18u CET Voortgang aandeleninkoopprogramma Fagron In de periode van 20 oktober 2025 tot en met 24 oktober 2025 heeft Fagron 45.000 eigen aandelen ingekocht voor een gemiddelde prijs van € 21,0115 per aandeel wat overeenkomt met een totaalbedrag van € 945.517,50. Deze aankopen zijn gedaan als onderdeel van het aandeleninkoopprogramma van maximaal 200.000 Fagron aandelen ter afdekking van Fagron’s verplichtingen uit hoofde van haar langetermijn variabele belonings...

 PRESS RELEASE

Fagron’s share buy-back program: Weekly update

Fagron’s share buy-back program: Weekly update Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 17 October 2025 – 6PM CET Fagron’s share buy-back program: Weekly update In the period from 16 October 2025 through 17 October 2025, Fagron purchased 20,000 of its owns shares at an average price of € 20.609 per share corresponding to a total amount of € 412,180.00. These purchases are part of the share buy-back program of up to 200,000 Fagron shares to fulfill Fagron’s obligations under its long-term incentive scheme, which was announced on 9 October 2025. The total numb...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch